These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. Boult JK; Walker-Samuel S; Jamin Y; Leiper JM; Whitley GS; Robinson SP J Pathol; 2011 Nov; 225(3):344-52. PubMed ID: 21590769 [TBL] [Abstract][Full Text] [Related]
3. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo. Papaevangelou E; Boult JKR; Whitley GS; Robinson SP; Howe FA Angiogenesis; 2018 Nov; 21(4):737-749. PubMed ID: 29721731 [TBL] [Abstract][Full Text] [Related]
5. Host microvasculature influence on tumor vascular morphology and endothelial gene expression. Roberts WG; Delaat J; Nagane M; Huang S; Cavenee WK; Palade GE Am J Pathol; 1998 Oct; 153(4):1239-48. PubMed ID: 9777955 [TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic activity of endostatin inhibits C6 glioma growth. Peroulis I; Jonas N; Saleh M Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365 [TBL] [Abstract][Full Text] [Related]
7. The role of tumour-derived iNOS in tumour progression and angiogenesis. Kostourou V; Cartwright JE; Johnstone AP; Boult JK; Cullis ER; Whitley G; Robinson SP Br J Cancer; 2011 Jan; 104(1):83-90. PubMed ID: 21139581 [TBL] [Abstract][Full Text] [Related]
8. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Smith CL; Birdsey GM; Anthony S; Arrigoni FI; Leiper JM; Vallance P Biochem Biophys Res Commun; 2003 Sep; 308(4):984-9. PubMed ID: 12927816 [TBL] [Abstract][Full Text] [Related]
9. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042 [TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Saleh M; Stacker SA; Wilks AF Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597 [TBL] [Abstract][Full Text] [Related]
12. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517 [TBL] [Abstract][Full Text] [Related]
13. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis. Singh JP Curr Opin Investig Drugs; 2007 Sep; 8(9):736-41. PubMed ID: 17729185 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells. Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664 [TBL] [Abstract][Full Text] [Related]
15. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Achan V; Tran CT; Arrigoni F; Whitley GS; Leiper JM; Vallance P Circ Res; 2002 Apr; 90(7):764-9. PubMed ID: 11964368 [TBL] [Abstract][Full Text] [Related]
16. The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium. Saleh M; Davis ID; Wilks AF Int J Cancer; 1997 Aug; 72(4):664-72. PubMed ID: 9259408 [TBL] [Abstract][Full Text] [Related]
17. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Ke LD; Shi YX; Im SA; Chen X; Yung WK Clin Cancer Res; 2000 Jun; 6(6):2562-72. PubMed ID: 10873113 [TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor-b in human astrocytoma. Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624 [TBL] [Abstract][Full Text] [Related]
19. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]